Scinovex
articleTop 1% cited

Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury

American Journal of Physiology-Renal Physiology · 2004 · Vol. 286(3) · pp. F552–F563

Abstract

Nephrotoxicity is a common side effect of therapeutic interventions, environmental insults, and exposure to toxicants in the workplace. Although biomarkers for nephrotoxicity are available, they often lack sensitivity and are not specific as indicators of epithelial cell injury. Kidney injury molecule-1 (Kim-1) is a type 1 membrane protein with extracellular immunoglobulin and mucin domains. The mRNA and protein for Kim-1 are expressed at very low levels in normal rodent kidney, but expression increases dramatically after injury in proximal tubule epithelial cells in postischemic rodent kidney and in humans during ischemic acute renal failure. To evaluate the utility of Kim-1 as a biomarker for other types of renal injury, we analyzed tissue and urinary expression in response to three different types of nephrotoxicants in the rat: S-(1,1,2,2-tetrafluoroethyl)-l-cysteine (TFEC), folic acid, and cisplatin. Marked increases in Kim-1 expression were confirmed by immunoblotting in all three models. The protein was shown to be localized to the proximal tubule epithelial cell by immunofluorescence. Furthermore, Kim-1 protein was detected in urine of toxicant-treated rats. The temporal pattern of expression in response to TFEC is similar to the Kim-1 expression pattern in the postischemic kidney. In folic acid-treated kidneys, Kim-1 is clearly localized to the apical brush border of the well-differentiated proximal tubular epithelial cells. After folic acid treatment, expression of Kim-1 is present in the urine despite no significant increase in serum creatinine. Cisplatin treatment results in early detection of urinary Kim-1 protein and diffuse Kim-1 expression in S3 cells of the proximal tubule. Kim-1 can be detected in the tissue and urine on days 1 and 2 after cisplatin administration, occurring before an increase in serum creatinine. The upregulation of expression of Kim-1 and its presence in the urine in response to exposure to various types of nephrotoxicants suggest that this protein may serve as a general biomarker for tubular injury and repair processes.

Chemotherapy-induced organ toxicity mitigationRenal and related cancersAcute Kidney Injury ResearchKidneyNephrotoxicityUrinary systemAcute kidney injuryBiomarkerLipocalinPathologyCreatinineMedicineChemistry

MeSH terms

AnimalsCisplatinCysteineFluorocarbonsFolic AcidHydrocarbons, FluorinatedImmunohistochemistryKidneyKidney DiseasesMaleMembrane ProteinsRats, Inbred F344BiomarkersCell Adhesion MoleculesRats, Sprague-Dawley
Citations
664
FWCI
15.27
field-weighted impact
References
41
Percentile
99%
vs. same field & year
Citations per year
Cited by
Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more
Nephrology Dialysis Transplantation · 2009 · 442 citations
Pathophysiology of Cisplatin-Induced Acute Kidney Injury
BioMed Research International · 2014 · 683 citations
Cardiorenal Syndrome
Journal of the American College of Cardiology · 2008 · 1,786 citations
Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease
The Journal of Pathology · 2007 · 471 citations
Intrinsic Epithelial Cells Repair the Kidney after Injury
Cell stem cell · 2008 · 861 citations
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.